juglanin

06/01/2018 - "In our study, the protective effects and anti-inflammatory activity of juglanin were investigated in mice and lung cells treated by lipopolysaccharide (LPS) to reveal the possible mechanism by which juglanin attenuates acute lung injury. "
06/01/2018 - "Thus, juglanin may be a potential candidate as dietary supplement for acute lung injury for children in future."
06/01/2018 - "Our results indicate that juglanin has a protective role in LPS-triggered acute lung injury via suppression of fibrosis and inflammation response by NF-κB signaling pathways inactivation. "
06/01/2018 - "Juglanin suppresses fibrosis and inflammation response caused by LPS in acute lung injury."

07/01/2018 - "Juglanin has been reported to exert marked protective effects in various diseases via the inhibition of inflammation and tumor cell growth. "
12/02/2017 - "Thus, the findings above indicated that juglanin, as a chemosensitizer, potentiate the anti-cancer role of DOX in drug-resistant cancer cells. "
01/01/2017 - "Finally, juglanin inhibited tumor growth in the mouse xenograft model in vivo. "
01/01/2020 - "Juglanin is a natural compound, reported to have an inhibitory effect on inflammation, oxidative stress and cancer progression. "
01/01/2017 - "Hence, juglanin might be a promising candidate for development of anti-tumor drugs targeting breast cancer."

06/01/2018 - "Juglanin dramatically reduced the inflammation of cell infiltration. "
01/01/2020 - "Nrf2 mitigates prolonged PM2.5 exposure-triggered liver inflammation by positively regulating SIKE activity: Protection by Juglanin."
12/01/2019 - "Taken together, we found that juglanin inhibits IL-1β-induced inflammation through the regulation of NF-κB signalling. "
12/01/2019 - "Juglanin has been reported to have anti-inflammation activity. "
12/01/2019 - "Juglanin inhibits IL-1β-induced inflammation in human chondrocytes."

07/01/2018 - "Juglanin ameliorates UVB‑induced skin carcinogenesis via anti‑inflammatory and proapoptotic effects in vivo and in vitro."

01/01/2018 - "Juglanin ameliorates LPS-induced neuroinflammation in animal models of Parkinson's disease and cell culture via inactivating TLR4/NF-κB pathway."